A New Dawn For Biotech? – Forbes
0
This week, much of the biotech investing world is in San Francisco for the annual J.P. Morgan Healthcare Conference. Old timers like me — I’ve attended nearly every year since 1998 — remember the infinitely more manageable Hambrecht & Quist conference, still quaintly known as H&Q. (The financial behemoth, then known as Chase Manhattan, acquired H&Q in late 1999 and the meeting has since grown more chaotic every year.) Now the confab overflows every available space in and around the venerable Westin St. Francis hotel, as hundreds of company executives try to convince investors they’ve got the next mega-blockbuster drug or paradigm-shifting idea. Although it’s enormously exhausting and by the second day I’m always telling myself it will be my last year, it’s also a great time to take stock of both sentiment and reality in the healthcare world.
Read more – Forbes